Lauren Silvernail

Lauren Silvernail possesses extensive experience in corporate governance and finance, serving as a member of the Board of Directors for multiple companies including Harrow, Harpoon Therapeutics, and Nicox, where responsibilities also include leadership roles such as Chair of the Audit and Nominating Committees. In executive positions, Lauren has held the roles of Chief Financial Officer and Executive Vice President of Corporate Development at Evolus, as well as Chief Business Officer and Chief Financial Officer at Revance Therapeutics. Academically, Lauren earned an MBA in Finance from UCLA Anderson School of Management and a BA in Biophysics from the University of California, Berkeley.